FindTrial
Sign In

A study on the early warning of cancer cachexia based on imaging omics

A study on the early warning of cancer cachexia based on imaging omics

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036231
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer cachexia

Interventions

Gold Standard:Clinical outcome
Index test:Prediction&#32
model&#32
of&#32
early&#32
warning&#32
cancer&#32
cachexia&#32
based&#32
on&#32
imaging&#32
omics

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: a.Patients with clearly diagnosed gastrointestinal cancer; b.The patient and his/her authorized representative sign the informed consent form and enter the trial voluntarily.

Exclusion criteria

Exclusion criteria: a. Patients with mental disorders; b. Age less than 18 years; c. Alcohol or substance abuse.

Design outcomes

Primary

MeasureTime frame
clinical outcomes;Accuracy and specificity, et al;survival;blood routine and biochemical tests;Image data;—

Countries

China

Contacts

Public ContactGuohao Wu

Department of General Surgery/Shanghai Clinical Nutrition Research Center, Zhongshan Hospital, Fudan University

wuguohaozs@163.com+86 021-64041990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026